Pharmacological Interventions

Intellectual Disability Psychiatry: A Practical Handbook

Volumn , Issue , 2009, Pages 203-222

  Deb, Shoumitro ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Assessment of capacity of person in giving informed consent to proposed intervention; Evidence to support withdrawing medication; Generalized anxiety disorder (GAD); Monitoring effectiveness of intervention; Non pharmacological interventions reassurance, anxiety management and cognitive behaviour therapy (CBT); Pharmacological interventions; Pharmacological treatment in mental disorders; Poly prescribing and problem behaviours; Psychotropic medications for psychiatric disorders for adults with intellectual disabilities; Treatment for refractory depression and electroconvulsive therapy (ECT)

Indexed keywords

EID: 84887610186     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470682968.ch14     Document Type: Chapter

References (11)

1. Taylor, D., Paton, C. and Kerwin, R. (2007) The Maudsley Prescribing Guidelines, Taylor & Francis, London.
2. Bhaumik S. and Branford D. (eds) (2008) The Frith Prescribing Guidelines: For Adults with Intellectual Disability, HealthComm UK Ltd, Aberdeen.
3. Deb, S., Thomas, M. and Bright, C. (2001) Mental disorder in adults with intellectual disability. 2: the rate of behaviour disorders among a community-based population aged between 16-64 years. Journal of Intellectual Disability Research, 45 (6), 506-514.
4. Deb, S., Clarke, D. and Unwin, G. (2006) Using Medication to Manage Behaviour Problems Among Adults with a Learning Disability: Quick Reference Guide (QRG), University of Birmingham, MENCAP, The Royal College of Psychiatrists, London, ISBN 0855370947. www.ld-medication.bham.ac.uk.
5. Royal College of Psychiatrists (RCPsych) (2001) DC-LD: Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation, Occasional Paper OP48, Gaskell Press, London.
6. Fletcher R., Loschen E., Stavrakaki C., and First M. (eds) (2007) Diagnostic Manual-Intellectual Disability (DM-ID): A Textbook of Diagnosis of Mental Disorders in Persons with Intellectual Disability, The National Association for the Dually Diagnosed (NADD) Press and the American Psychiatric Association (APA), Washington, DC.
7. Unwin, G. and Deb, S. (2008) Use of medication for the management of behaviour problems among adults with intellectual disabilities: a clinicians' consensus survey. American Journal on Mental Retardation, 113 (1), 19-31.
8. Ahmed, Z., Fraser, W., Kerr, M.P. et al. (2000) Reducing antipsychotic medication in people with a learning disability. The British Journal of Psychiatry, 178, 42-46.
9. Branford, D. (1996) Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities. Journal of Intellectual Disability Research, 40, 322-329.
10. National Institute of Clinical Excellence. www.nice.org.uk.
11. Psychotropic medication leaflets accessible version: www.ld-medication.bham.ac.uk.